Facial Injectables Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Facial Injectables Market in 2025 is estimated at USD 13.24 billion. The global market size crossed USD 12.18 billion in 2024 and it is set to experience impressive growth, with a CAGR above 10.9%, to exceed USD 46.75 billion by 2037. North America is forecasted to hit USD 14.96 billion by 2037, led by rising spending on cosmetics and appearance.
The growth of the facial injectables market is set to be dominated by growing concerns among the geriatric population related to face wrinkles, fine lines, and volume loss. For instance, as per the predictions of the World Health Organization, 1 in 6 people across the globe by 2030, is predicted to be aged 60 years or over. Therefore, facial injectables are ideal for the aged population who want fresh skin.
Facial Injectables Sector: Growth Drivers and Challenges
Growth Drivers
- Growing consciousness among people regarding beauty - Social media has an enormous effect on millennial shopping decisions. Close to 4 billion population were utilizing social media worldwide in 2024, this number is estimated to rise to about 5 billion in 2028. Hence, the increasing influence of social media, combined with globalization, has resulted in an amalgamation of beauty notions, especially those relating to facial features. Owing to this, the market is predicted to rise over the years to come.
- Rising trend of minimally invasive surgeries - Minimally invasive operations are rapidly supplanting intrusive procedures, incorporating the global facial injectables market's expansion. For instance, according to the American Society of Plastic Surgeons (ASPS), approximately 26.2 million minimally invasive and surgical cosmetics were performed in the United States in 2022, indicating a rise of 19% as compared to the year 2019. Moreover, minimally invasive surgeries are poised to cause the least pain and have reduced recovery time. As a consequence, the popularity of minimally invasive activities is growing which in addition contributes to market expansion.
- Surging advancement of facial injectables - The development and implementation of new technology in the face injection business additionally serve to strengthen the market. One of the most significant developments is the use of imaging technologies and mapping software to assess a patient's facial structure in great detail. This allows clinicians to design injections with greater precision, optimizing the dispersion of the filler for the most natural and pleasing results. Advances in methodologies and technologies have therefore led to the rising popularity of dermal fillers. For instance, the creation of novel and refined filler formulations resulted in improved outcomes, longer-lasting results, and fewer adverse effects. Consequently, this has boosted the confidence of individuals in these treatments and encouraged them to look into getting dermal fillers. Therefore, the market is set to expand.
Challenges
- Growing side effects of facial injectables - Fillers are among the most frequently employed cosmetics. They are typically well tolerated, however any of them can occasionally have severe side effects. Adverse consequences frequently last as long as the filler is in the skin, indicating that short-lived fillers possess short-term side effects and permanent fillers may cause long-term negative effects. Supreme care needs to be taken to avoid infections, and the method of injection must be perfect. Therefore, the market for facial injectables is expected to be hindered.
- Fluctuations in price of raw material - Raw material costs for face injectables are influenced by supply and demand trends. Raw material supply fluctuations may trigger price volatility. Natural disasters, political disruptions, worldwide emergencies, and economic situations can all have an impact on the supply chain, causing raw material pricing changes.
- Lack of awareness among people
Facial Injectables Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.9% |
|
Base Year Market Size (2024) |
USD 12.18 billion |
|
Forecast Year Market Size (2037) |
USD 46.75 billion |
|
Regional Scope |
|
Facial Injectables Segmentation
Product (Collagen, Hyaluronic Acid [HA], Botulinum Toxin Type A, Calcium Hydroxylapatite [CaHA], Polymer Fillers)
By the end of 2037, botulinum toxic type A segment is expected to account for remarkable facial injectables market share. Botulinum toxin type A, additionally referred to as Botox, is a key component in the cosmetic injectables industry because it targets the underlying cause of wrinkles that result from muscle spasms. Unlike fillers, which enhance volume, Botox works by briefly relaxing certain facial muscles. This eliminates recurrent muscle contractions, which allow wrinkles to develop and deepen, especially on the top face.
Botox injections are very effective in treating frown lines, crow's feet, and forehead wrinkles. Therefore, with the growing prevalence of wrinkles, the segment is set to observe exponential growth. Furthermore, this prevalence could be influenced not only by old age but also by growing consumption of smoking, pollution, and more. For instance, according to the International Energy Agency, CO2 emissions in 2021 across the globe rose by over 2 billion which is the highest in history. Therefore, with the growing prevalence of people with wrinkles, the segment is estimated to expand.
Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement, Others)
By the end of 2037, facelift segment is poised to account for substantial facial injectables market share. The main benefits of facial injectables for facelift utilization over other surgical solutions involve minimally invasive techniques with no downtime or incisions, natural-looking results, a gradual approach that motivates patients to choose conservative treatment, and an affordable strategy with shorter recovery time and no anesthesia required. There are several limits, including transient results and a less favorable method for individuals with substantial sagging and deep wrinkles.
Overall, facial injectables are a successful technique for obtaining a non-surgical facelift result. They provide an effective way to achieve a more young and refreshed appearance. Furthermore, the rising disposable income is also encouraging segment growth. According to Euromonitor International, the worldwide disposable incomes and expenditure per household in 2022 are both anticipated to increase by 2.6%.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Application |
|
|
End-User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Facial Injectables Industry - Regional Synopsis
North American Market Statistics
North America facial injectables market share is predicted to cross 32% by 2037. This growth of the market in this region is set to be dominated by rising spending on cosmetics. In 2022, it was predicted that over USD 721 will be spent by people in America on appearance. Hence, the demand for facial injectables is also set to rise over the projected timeframe.
The market in the US for facial injectables is predicted to gather the highest market revenue over the forecast period. This could be owing to the rising number of young population in this region.
Additionally, the Canadian market is also set to experience growth in this region on account of the growing consumption of alcohol which is causing premature aging.
APAC Market Analysis
Asia Pacific region in facial injectables market is estimated to account for significant revenue share by the end of 2037. The major factor driving the market expansion in this region is the growing middle-class population. As per the predictions of the World Economic Forum, in 2020, over 2 billion population of Asians were middle class and this number is poised to grow to 3.5 billion by 2030. Hence, the spending of the middle-class population is also high on appearance.
In this region, the market in China for facial injectables is poised to rise at a revenue of USD 3.63 billion over the years to come owing to the growing urban population.
Moreover, with the surge in investment in surgical procedures the market in India for facial injectables is projected to have notable growth.
Furthermore, the market in South Korea is also expected to expand at a significant pace. This growth is set to be encouraged by a larger number of options available.
Companies Dominating the Facial Injectables Landscape
- Abbvie Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medytox
- Galderma
- Sinclair Ltd.
- Merz Pharma
- SciVision Biotech Inc
- NovaCutis, Inc
- Bioplus Co. Ltd
- Suneva Medical
- Ipsen Pharma
The facial injectables market consists of a number of major players who are launching various products in the market which is additionally influencing the market growth. Some of them include:
Recent Developments
- Galderma announced the approval from Health Canada for a hyaluronic acid (HA) injectable, Restylane SHAYPE, designed for temporary augmentation of the chin region.
- Suneva Medical, Inc., announces the recommence of South Korea post-COVID and an extension for Bellafill within this main global aesthetic market through a new distribution partnership with Renaissance Bio.
Author Credits: Radhika Pawar
- Report ID: 4442
- Published Date: Apr 18, 2025
- Report Format: PDF, PPT
